WWTR1 and metastatic malignant neoplasm: Here, we discuss how abnormal YAP/TAZ activity promotes cancer formation, progression, and metastasis, and how YAP/TAZ and their upstream regulators or their downstream target genes are potential therapeutic targets for preventing and treating metastatic cancer.